195 related articles for article (PubMed ID: 21907750)
21. Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination.
Gimeno IM; Cortes AL; Guy JS; Turpin E; Williams C
Avian Pathol; 2011 Aug; 40(4):395-403. PubMed ID: 21812719
[TBL] [Abstract][Full Text] [Related]
22. Pathotyping of Australian isolates of Marek's disease virus in commercial broiler chickens vaccinated with herpesvirus of turkeys (HVT) or bivalent (HVT/SB1) vaccine and association with viral load in the spleen and feather dander.
Walkden-Brown SW; Islam A; Islam AF; Burgess SK; Groves PJ; Cooke J
Aust Vet J; 2013 Aug; 91(8):341-50. PubMed ID: 23889101
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge.
Islam AF; Wong CW; Walkden-Brown SW; Colditz IG; Arzey KE; Groves PJ
Avian Pathol; 2002 Oct; 31(5):449-61. PubMed ID: 12427339
[TBL] [Abstract][Full Text] [Related]
24. Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease.
Baigent SJ; Petherbridge LJ; Smith LP; Zhao Y; Chesters PM; Nair VK
J Gen Virol; 2006 Apr; 87(Pt 4):769-776. PubMed ID: 16528024
[TBL] [Abstract][Full Text] [Related]
25. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.
Reddy SK; Sharma JM; Ahmad J; Reddy DN; McMillen JK; Cook SM; Wild MA; Schwartz RD
Vaccine; 1996 Apr; 14(6):469-77. PubMed ID: 8782342
[TBL] [Abstract][Full Text] [Related]
26. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
27. HVT-vectored H7 vaccine protects chickens from lethal infection with the highly pathogenic H7N9 Avian influenza virus.
Chen YQ; Su GM; Zhang JH; Li B; Ma KX; Zhang X; Huang LH; Liao M; Qi WB
Vet Microbiol; 2023 Oct; 285():109852. PubMed ID: 37683421
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
[TBL] [Abstract][Full Text] [Related]
30. Prevention of Marek's disease: a review.
Purchase HG
Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
[TBL] [Abstract][Full Text] [Related]
31. Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection.
Zou Z; Huang K; Wei Y; Chen H; Liu Z; Jin M
Sci Rep; 2017 May; 7(1):1478. PubMed ID: 28469192
[TBL] [Abstract][Full Text] [Related]
32. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
[TBL] [Abstract][Full Text] [Related]
33. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.
Qiao CL; Yu KZ; Jiang YP; Jia YQ; Tian GB; Liu M; Deng GH; Wang XR; Meng QW; Tang XY
Avian Pathol; 2003 Feb; 32(1):25-32. PubMed ID: 12745375
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses.
van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I
Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529
[TBL] [Abstract][Full Text] [Related]
35. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
[TBL] [Abstract][Full Text] [Related]
36. Herpesvirus of turkey-vectored avian influenza vaccine offers cross-protection against antigenically drifted H5Nx highly pathogenic avian influenza virus strains.
Nassif S; Zaki F; Mourad A; Fouad E; Saad A; Setta A; Felföldi B; Mató T; Kiss I; Palya V
Avian Pathol; 2020 Dec; 49(6):547-556. PubMed ID: 32615785
[TBL] [Abstract][Full Text] [Related]
37. Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection.
Zou Z; Hu Y; Liu Z; Zhong W; Cao H; Chen H; Jin M
Vet Res; 2015 Apr; 46(1):42. PubMed ID: 25889564
[TBL] [Abstract][Full Text] [Related]
38. Marek's disease tumors in chickens vaccinated with turkey herpesvirus vaccine.
Eidson CS
Dev Biol Stand; 1982; 52():437-46. PubMed ID: 7166202
[TBL] [Abstract][Full Text] [Related]
39. Protection Efficacy of Recombinant HVT-ND-LT and the Live Attenuated Tissue Culture Origin Vaccines Against Infectious Laryngotracheitis Virus When Administered Individually or in Combination.
Becerra R; Maekawa D; García M
Avian Dis; 2023 Jun; 67(2):145-152. PubMed ID: 37556293
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous construction strategy using two types of fluorescent markers for HVT vector vaccine against infectious bursal disease and H9N2 avian influenza virus by NHEJ-CRISPR/Cas9.
Zhang JF; Shang K; Kim SW; Park JY; Wei B; Jang HK; Kang M; Cha SY
Front Vet Sci; 2024; 11():1385958. PubMed ID: 38812565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
